4
Changes in Ownership
NewAmsterdam Pharma Co N.V. Filed Acc 0001193125-26-025012
Chief Accounting Officer sold 72,572 shares at an average $33.29 ($2,415,843)
- Chief Accounting Officer acquired 72,572 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kooij Louise Frederika · Chief Accounting Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-23 | Exercise or conversion : show line 1 in the form 10b5-1 | +38,172 | $10.90 | $416,075 | 62,525 | D |
| 2026-01-23 | Sale : show line 2 in the form 10b5-1 | −25,405 | $33.44 | $849,543 | 37,120 | D |
| 2026-01-23 | Sale : show line 3 in the form 10b5-1 | −12,767 | $34.37 | $438,802 | 24,353 | D |
| 2026-01-26 | Exercise or conversion : show line 4 in the form 10b5-1 | +34,400 | $10.90 | $374,960 | 58,753 | D |
| 2026-01-26 | Sale : show line 5 in the form 10b5-1 | −34,091 | $32.77 | $1,117,162 | 24,662 | D |
| 2026-01-26 | Sale : show line 6 in the form 10b5-1 | −309 | $33.45 | $10,336 | 24,353 | D |
| Open-market sales · 72,572 sh · avg $33.29 · $2,415,843 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-23 | Exercise or conversion : show line 7 in the form 10b5-1 Option (right to buy) | −38,172 | 179,962 | D |
| 2026-01-26 | Exercise or conversion : show line 8 in the form 10b5-1 Option (right to buy) | −34,400 | 145,562 | D |
Loading xslF345X05/ownership.xml…